Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine

International Journal of Neuropsychopharmacology

Volumn 13, Issue 8, 2010, Pages 1079-1088

  Zanoveli, Janaina M ^a   Pobbe, Roger L H ^a   De Bortoli, Valquiria C ^a   Carvalho, Milene C ^a   Brando, Marcus L ^a   Zangrossi Jr , Helio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dorsal periaqueductal grey matter; elevated T maze; fluoxetine; microdialysis; panic disorder

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPANIC AGENT; BUSPIRONE; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; ANXIOLYTIC AGENT; SEROTONIN 1 ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC DRUG ADMINISTRATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; IN VIVO STUDY; INJECTION; LONG TERM CARE; MALE; MAZE TEST; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PANICOLYTIC LIKE EFFECT; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; THERAPY EFFECT; WISTAR RAT; ANIMAL; COMPARATIVE STUDY; METABOLISM; PANIC; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; ANTI-ANXIETY AGENTS; FLUOXETINE; MALE; PANIC DISORDER; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SYNAPTIC TRANSMISSION;

EID: 77957240289     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114570999099X     Document Type: Article

References (63)

1. Bandler R, Carrive P, Zhang SP (1991). Integration of somatic and autonomic reactions within the midbrain periaqueductal grey: viscerotopic, somatotopic and functional organization. Progress in Brain Research 87, 269-305.
2. Beck SG, Birnstiel S, Choi KC, Pouliot WA (1997). Fluoxetine selectively alters 5-hydroxytryptamine1A and gamma-aminobutyric acid receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells. Journal of Pharmacology and Experimental Therapeutics 281,115-122. (Pubitemid 27203058)
3. Beyer CE, Cremers TI (2008). Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin? European Journal of Pharmacology 580, 350-354.
4. Blanchard DC, Griebel G, Blanchard RJ (2003). The mouse defense test battery: pharmacological and behavioral assays for anxiety and panic. European Journal of Pharmacology 463, 97-116. (Pubitemid 36205074)
5. Blanchard DC, Griebel G, Rodgers RJ, Blanchard RJ (1998). Benzodiazepine and serotonergic modulation of antipredator and conspecific defense. Neuroscience and Biobehavioral Reviews 22, 597-612. (Pubitemid 28304900)
6. Boix F, Sandor P, Nogueira PJ, Huston JP, et al. (1995). Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience 64, 1045-1055.
7. Borelli KG, Nobre MN, Brandao ML, Coimbra NC (2004). Effects of acute and chronic fluoxetine and diazepam on freezing behavior induced by electrical stimulation of dorsolateral and lateral columns of the periaqueductal gray matter. Pharmacology, Biochemistry and Behavior 77, 557-566.
8. Bosker FJ, Cremers TI, Jongsma ME, Westerink BH, et al. (2001). Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala. Journal of Neurochemistry 76,1645-1653.
9. Brandao ML, Zanoveli JM, Ruiz-Martinez RC, Oliveira LC, et al. (2008). Different patterns of freezing behavior organized in the periaqueductal gray of rats: association with different types of anxiety. Behavioural Brain Research 188, 1-13.
10. Connor KM, Davidson JR (1998). Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biological Psychiatry 44, 1286-1294. (Pubitemid 29015866)
11. Czachura JF, Rasmussen K (2000). Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn-Schmiedeberg's Archives of Pharmacology 362, 266-275.
12. Dahlstrijm A, Fuxe K (1964). Localization of monoamines in the lower brain stem. Experientia 20, 398-399.
13. Dawson LA, Nguyen HQ, Smith DL, Schechter LE (2002). Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex. Journal of Psychopharmacology 16,145-152.
14. de Bortoli VC, Nogueira RL, Zangrossi Jr. H (2006). Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray. Psychopharmacology 183, 422-428.
15. de Bortoli VC, Nogueira RL, Zangrossi Jr. H (2008). Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal gray. Psychopharmacology 198, 341-349.
16. Del-Ben CM, Graeff FG (2009). Panic disorder: is the PAG involved? Neural Plasticity 2009,1-9.
17. den Boer JA, Slaap BR (1998). Review of current treatment in panic disorder. International Clinical Psychopharmacology 13 (Suppl. 4), 25-30.
18. de Paula Soares V, Zangrossi Jr. H (2004). Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze. Brain Research Bulletin 64, 181-188.
19. Dremencov E, Gur E, Lerer B, Newman ME (2003). Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Progress in Neuro-Psychopharmacology & Biological Psychiatry 27, 729-739. (Pubitemid 36966753)
20. Elena Castro M, Diaz A, del Olmo E, Pazos A (2003). Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 44, 93-101. (Pubitemid 36135846)
21. Felton TM, Kang TB, Hjorth S, Auerbach SB (2003). Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology 367, 297-305. (Pubitemid 36408012)
22. Fuller RW, Snoddy HD, Perry KW, Bymaster FP, et al. (1978). Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin comparison of fluoxetine and chlorimipramine. Biochemical Pharmacology 27, 193-198.
23. Gardier AM, Malagie I, Trillat AC, Jacquot C, et al. (1996). Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundamental & Clinical Pharmacology 10, 16-27. (Pubitemid 126426097)
24. Gentil V (1988). The aversive system, 5HT and panic attacks. In: Simon P, Soubrie P, Widlocher D (Eds), Animal Models of Psychiatric Disorders (pp. 142-145). Basel: Karger.
25. Graeff FG (1990). Brain defense systems and anxiety. In: Burrows GD, Roth M, Noyes Jr. R (Eds), Handbook of Anxiety: The Neurobiology of Anxiety (pp. 307-354). Amsterdam: Elsevier Science Publishers.
26. Graeff FG (2002). On serotonin and experimental anxiety. Psychopharmacology 163, 467-476.
27. Graeff FG (2004). Serotonin, the periaqueductal gray and panic. Neuroscience and Biobehavioral Reviews 28, 239-259.
28. Graeff FG, Silveira MC, Nogueira RL, Audi EA, et al. (1993). Role of the amygdala and periaqueductal gray in anxiety and panic. Behavioural Brain Research 58, 123-131.
29. Graeff FG, Zangrossi Jr. H (2002). Animal models of anxiety disorders. In: D'haenen H, Den Boer JA, Westenberg H, Willner P (Eds), Textbook of Biological Psychiatry (pp. 879-893). London: Wiley and Sons.
30. Gray JA, McNaughton N (2000). The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System (p. 424). Oxford: Oxford University Press.
31. Green AL, Wang S, Owen SL, Xie K, et al. (2005). Deep brain stimulation can regulate arterial blood pressure in awake humans. Neuroreport 16, 1741-1745. (Pubitemid 41547039)
32. Hervas I, Vilaro MT, Romero L, Scorza MC, et al. (2001). Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24, 11-20.
33. Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, et al. (2000). Serotonin autoreceptor function and antidepressant drug action. Journal of Psychopharmacology 14, 177-185. (Pubitemid 30389492)
34. Invernizzi R, Bramante M, Samanin R (1996). Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacology, Biochemistry and Behavior 54, 143-147. (Pubitemid 26146667)
35. Jacob CA, Cabral AH, Almeida LP, Magierek V et al. (2002). Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray. Pharmacology, Biochemistry and Behavior 72, 761-766. (Pubitemid 34621302)
36. Jenck F, Moreau JL, Martin JR (1995). Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Research 57, 181-191.
37. Johnson DA, Grant EJ, Ingram CD, Gartside SE (2007). Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant. Biological Psychiatry 62, 1228-1235.
38. Kreiss DS, Lucki I (1995). Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. Journal of Pharmacology and Experimental Therapeutics 274, 866-876.
39. Lovick TA (2000). Panic disorder - a malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter. Neuroscientist: a Review Journal Bringing Neurobiology, Neurology and Psychiatry 6, 48-59.
40. Macedo CE, Martinez RCR, Souza Silva MA, Brandao ML (2005). Increases in extracellular levels of 5-HT and dopamine in the basolateral, but not in the central, nucleus of amygdala induced by aversive stimulation of the inferior colliculus. European Journal of Neuroscience 21, 1131-1138. (Pubitemid 40461065)
41. Martinez RCR, Oliveira AR, Macedo CE, Brandao ML (2008). Involvement of dopaminergic mechanisms in the nucleus accumbens core and shell subregions in the expression of fear conditioning. Neuroscience Letters 446, 112-116.
42. Mongeau R, Marsden CA (1997). Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats. Psychopharmacology 131, 321-328. (Pubitemid 27348697)
43. Nash JR, Sargent PA, Rabiner EA, Hood SD, et al. (2008). Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. British Journal of Psychiatry 93, 229-234.
44. Nashold Jr. BS, Wilson WP, Slaughter DG (1969). Sensations evoked by stimulation in the midbrain of man. Journal of Neurosurgery 30, 14-24.
45. Nierenberg AA, Farabaugh AH, Alpert JE, Gordon J, et al. (2000). Timing of onset of antidepressant response with fluoxetine treatment. American Journal of Psychiatry 157, 1423-1428.
46. Nogueira RL, Graeff FG (1995). Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacology, Biochemistry and Behavior 52, 1-6.
47. Olds ME, Olds J (1962). Approach-escape interactions in rat brain. American Journal of Physiology 203, 803-810.
48. Paxinos G, Watson C (2007). The Rat Brain in Stereotaxic Coordinates, 6th edn. London: Academic Press.
49. Pinheiro SH, Zangrossi Jr. H, Del-Ben CM, Graeff FG (2007). Elevated mazes as animal models of anxiety: effects of serotonergic agents. Anais da Academia Brasileira de Ciencias 79, 71-85. (Pubitemid 46516260)
50. Pobbe RL, Zangrossi Jr. H (2005). 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. Psychopharmacology 183, 314-321.
51. Poltronieri SC, Zangrossi Jr. H, de Barros Viana M (2003). Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behavioural Brain Research 147, 185-192. (Pubitemid 37491426)
52. Rossi DV, Burke TF, McCasland M, Hensler JG (2008). Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline. Journal of Neurochemistry 105, 1091-1099. (Pubitemid 351590776)
53. Schenberg LC, Bittencourt AS, Sudre EC, Vargas LC (2001). Modeling panic attacks. Neuroscience and Biobehavioral Reviews 25, 647-659.
54. Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, et al. (1990). Fluoxetine in panic disorder. Journal of Clinical Psychopharmacology 10,119-121. (Pubitemid 20137608)
55. Schutz MT, de Aguiar JC, Graeff FG (1985). Anti-aversive role of serotonin in the dorsal periaqueductal grey matter. Psychopharmacology 85, 340-345.
56. Shen C, Li H, Meller E (2002). Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTP gamma S binding in rat brain regions. Neuropharmacology 42,1031-1038. (Pubitemid 34790258)
57. Vertes RP (1991). A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. Journal of Comparative Neurology 313, 643-668.
58. Viana MB, Graeff FG, Ltischmann PA (1997). Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray. Pharmacology, Biochemistry and Behavior 58, 167-172.
59. Wegener G, Bandpey Z, Heiberg IL, Mork A, et al. (2003). Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat. Psychopharmacology 166,188-194. (Pubitemid 36313127)
60. Young RF (1989). Brain and spinal stimulation: how and to whom! Clinical Neurosurgery 35, 429-447.
61. Zanoveli JM, Nogueira RL, Zangrossi Jr. H (2003). Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze. European Journal of Pharmacology 473, 153-161.
62. Zanoveli JM, Nogueira RL, Zangrossi Jr. H (2005). Chronic imipramine treatment sensitizes 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. Behavioural Pharmacology 16, 543-552.
63. Zanoveli JM, Nogueira RL, Zangrossi Jr. H (2007). Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Neuropharmacology 52, 1188-1195. (Pubitemid 46319209)